Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Neurology at the border of centuries: achievements and prospects].
Platelets and neurovascular inflammation.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
The prevalence of incidental findings in multiple sclerosis patients.
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
Implications of water channel proteins in selected neurological disorders: Epilepsies, muscular dystrophies, amyotrophic lateral sclerosis, neuromyelitis optica, Parkinson's disease, and spongiform encephalopathies.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
Nature plus nurture: the triggering of multiple sclerosis.
Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Pages
« first
‹ previous
…
328
329
330
331
332
333
334
335
336
…
next ›
last »